OnKure Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | 11/17/2025 | 2.84 M | $7.81 M | 0.00% | 21.02% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.02 M | $2.80 M | -6.67% | 7.53% |
| SHAY CAPITAL LLC | 11/14/2025 | 917.93 K | $2.52 M | 17.38% | 6.79% |
| VANGUARD GROUP INC | 11/07/2025 | 678.23 K | $1.87 M | -4.03% | 5.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11/10/2025 | 650.22 K | $1.79 M | -2.02% | 4.81% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 635.00 K | $1.75 M | 0.00% | 4.70% |
| BLACKROCK, INC. | 11/12/2025 | 564.84 K | $1.55 M | 0.01% | 4.18% |
| STEPSTONE GROUP LP | 11/14/2025 | 491.94 K | $1.35 M | 0.00% | 3.64% |
| CANTOR FITZGERALD, L. P. | 12/01/2025 | 491.86 K | $1.35 M | -26.54% | 3.64% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2025 | 478.55 K | $1.32 M | 0.00% | 3.54% |
| CARLYLE GROUP INC. | 11/07/2025 | 269.90 K | $742.21 K | 0.00% | 2.00% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 267.96 K | $736.89 K | 67.80% | 1.98% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 175.75 K | $483.31 K | 43.31% | 1.30% |
| RANGELEY CAPITAL, LLC | 11/14/2025 | 155.49 K | $427.60 K | 420.00% | 1.15% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 116.40 K | $320.09 K | -31.23% | 0.86% |
| AISLING CAPITAL MANAGEMENT LP | 11/12/2025 | 88.61 K | $243.67 K | 0.00% | 0.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 84.90 K | $233.48 K | 0.00% | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 60.45 K | $166.25 K | 0.00% | 0.45% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 59.22 K | $163.00 K | 172.11% | 0.44% |
| ALDEBARAN CAPITAL, LLC | 11/10/2025 | 44.00 K | $120.99 K | -0.40% | 0.33% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 26.61 K | $73.17 K | -0.82% | 0.20% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 25.44 K | $69.95 K | -1.65% | 0.19% |
| NORTHERN TRUST CORP | 11/14/2025 | 22.51 K | $61.90 K | 0.00% | 0.17% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 19.50 K | $53.63 K | -22.00% | 0.14% |
| MORGAN STANLEY | 11/14/2025 | 17.21 K | $47.34 K | 3.07% | 0.13% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 9.50 K | $26.13 K | 24.67% | 0.07% |
| CITIGROUP INC | 11/10/2025 | 3.32 K | $9.14 K | 1,224.30% | 0.02% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 11/10/2025 | 2.25 K | $6.19 K | -12.62% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.94 K | $5.32 K | 5.62% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 896 | $2.46 K | 5.66% | 0.01% |
| BARCLAYS PLC | 11/12/2025 | 621 | $1.71 K | -37.65% | 0.00% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 11/03/2025 | 497 | $1.37 K | 0.40% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 423 | $1.16 K | 174.68% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 364 | $1.00 K | 9.31% | 0.00% |
| GF FUND MANAGEMENT CO. LTD. | 11/07/2025 | 271 | $745 | -13.42% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 205 | $564 | 13.26% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 190 | $1.00 K | -23.08% | 0.00% |
| TRUST CO OF TOLEDO NA /OH/ | 10/16/2025 | 136 | $374 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 100 | $275 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 56 | $154 | 0.00% | 0.00% |
| FMR LLC | 11/13/2025 | 50 | $138 | 100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 6 | $17 | 0.00% | 0.00% |
| BAILARD, INC. | 10/30/2025 | 0 | $0 | -100.00% | 0.00% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
OnKure Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of OnKure Therapeutics, Inc.. The most heavily invested institutionals were:
ACORN CAPITAL ADVISORS, LLC: 2.84 M
CITADEL ADVISORS LLC: 1.02 M
Shay Capital LLC: 917,934
VANGUARD GROUP INC: 678,226
HIGHBRIDGE CAPITAL MANAGEMENT LLC: 650,218
Vestal Point Capital, LP: 635,000
75.65% of OnKure Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.22 M shares in the last 24 months. This purchase volume represents approximately $34.85 M in transactions.